Inhibition of Growth and Induction of Differentiation of Metastatic Melanoma Cells in Vitro by Genistein: Chemosensitivity is Regulated by Cellular P53

Overview

Journal Br J Cancer

Specialty Oncology

Date 1997 Jan 1

PMID 9184169

Citations 12

Authors

S Rauth

J Kichina

A Green

Affiliations

Soon will be listed here.

Abstract

We have investigated the effect of the soybean isoflavone genistein on the growth and differentiation of human melanoma cells. Four human melanoma cell lines, either completely lacking or containing different levels of wild-type p53, were treated with genistein in vitro in culture. It has been found that genistein significantly inhibited cell growth and that the chemosensitivity might depend on cellular p53 content. Specifically, the data suggest that high levels of wild-type p53 expression make cells resistant to genistein's growth-inhibitory action. Further support for this observation came from the stable transfection studies in which p53 transfectants expressing high levels of wild-type p53 became resistant to genistein. With respect to cell differentiation, our study showed that genistein increased melanin content and tyrosinase activity and caused the cells to form dendrite-like structures. Cells lacking p53 responded more than cells with p53 to dendrite-like structure formation. We also observed that genistein-induced differentiation involved an increase in tyrosinase mRNA level; the mechanisms by which genistein increases tyrosinase transcripts remain to be elucidated. Genistein treatment of the melanoma cell lines resulted in cell cycle arrest at G2/M check point and no significant apoptosis was observed.

Citing Articles

Phytochemicals in Skin Cancer Prevention and Treatment: An Updated Review.

Ng C, Yen H, Hsiao H, Su S Int J Mol Sci. 2018; 19(4).

PMID: 29565284 PMC: 5979545. DOI: 10.3390/ijms19040941.

Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility.

Marzagalli M, Montagnani Marelli M, Casati L, Fontana F, Moretti R, Limonta P Front Endocrinol (Lausanne). 2016; 7:140.

PMID: 27833586 PMC: 5080294. DOI: 10.3389/fendo.2016.00140.

Phytochemicals for the Management of Melanoma.

Pal H, Hunt K, Diamond A, Elmets C, Afaq F Mini Rev Med Chem. 2016; 16(12):953-79.

PMID: 26864554 PMC: 4980238. DOI: 10.2174/1389557516666160211120157.

Induction of melanogenesis by 4'-O-methylated flavonoids in B16F10 melanoma cells.

Horibe I, Satoh Y, Shiota Y, Kumagai A, Horike N, Takemori H J Nat Med. 2012; 67(4):705-10.

PMID: 23208771 DOI: 10.1007/s11418-012-0727-y.

Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR.

Medjakovic S, Mueller M, Jungbauer A Nutrients. 2012; 2(3):241-79.

PMID: 22254019 PMC: 3257647. DOI: 10.3390/nu2030241.

References

Kiguchi K, Constantinou A, Huberman E . Genistein-induced cell differentiation and protein-linked DNA strand breakage in human melanoma cells. Cancer Commun. 1990; 2(8):271-7. DOI: 10.3727/095535490820874218. View

Constantinou A, Kiguchi K, Huberman E . Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 1990; 50(9):2618-24. View

Noonan K, Beck C, Holzmayer T, Chin J, Wunder J, Andrulis I . Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A. 1990; 87(18):7160-4. PMC: 54703. DOI: 10.1073/pnas.87.18.7160. View

Watanabe T, Kondo K, Oishi M . Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res. 1991; 51(3):764-8. View

Messina M, Barnes S . The role of soy products in reducing risk of cancer. J Natl Cancer Inst. 1991; 83(8):541-6. DOI: 10.1093/jnci/83.8.541. View

Peterson G, Barnes S . Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun. 1991; 179(1):661-7. DOI: 10.1016/0006-291x(91)91423-a. View

Kondo K, Tsuneizumi K, Watanabe T, Oishi M . Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res. 1991; 51(19):5398-404. View

Kastan M, Onyekwere O, Sidransky D, Vogelstein B, Craig R . Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991; 51(23 Pt 1):6304-11. View

Faber K, Hughes Jr C . The effect of neonatal exposure to diethylstilbestrol, genistein, and zearalenone on pituitary responsiveness and sexually dimorphic nucleus volume in the castrated adult rat. Biol Reprod. 1991; 45(4):649-53. DOI: 10.1095/biolreprod45.4.649. View

10.

Schweigerer L, Christeleit K, Fleischmann G, Adlercreutz H, Wahala K, Hase T . Identification in human urine of a natural growth inhibitor for cells derived from solid paediatric tumours. Eur J Clin Invest. 1992; 22(4):260-4. DOI: 10.1111/j.1365-2362.1992.tb01460.x. View

11.

Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z . Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 1992; 52(22):6200-8. View

12.

Kastan M, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh W . A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992; 71(4):587-97. DOI: 10.1016/0092-8674(92)90593-2. View

13.

Lowe S, Schmitt E, Smith S, Osborne B, Jacks T . p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 1993; 362(6423):847-9. DOI: 10.1038/362847a0. View

14.

Peterson G, Barnes S . Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate. 1993; 22(4):335-45. DOI: 10.1002/pros.2990220408. View

15.

Brozena S, Fenske N, PEREZ I . Epidemiology of malignant melanoma, worldwide incidence, and etiologic factors. Semin Surg Oncol. 1993; 9(3):165-7. View

16.

Rauth S, Davidson R . Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene. Somat Cell Mol Genet. 1993; 19(3):285-93. DOI: 10.1007/BF01233076. View

17.

Wei H, Wei L, Frenkel K, Bowen R, Barnes S . Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr Cancer. 1993; 20(1):1-12. DOI: 10.1080/01635589309514265. View

18.

Pagliacci M, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F . Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur J Cancer. 1993; 29A(11):1573-7. DOI: 10.1016/0959-8049(93)90297-s. View

19.

Limtrakul P, Suttajit M, Semura R, Shimada K, Yamamoto S . Suppressive effect of soybean milk protein on experimentally induced skin tumor in mice. Life Sci. 1993; 53(21):1591-6. DOI: 10.1016/0024-3205(93)90182-3. View

20.

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View